Gallion Health Names Yale New Haven Health Development Partner and Investor

Gallion Health has named Yale New Haven Health (YNHHS) as a development partner and investor as the healthcare technology company expands its bill-only supply chain platform across one of Connecticut’s largest health systems.

The partnership, announced on August 19, will see YNHHS pilot Gallion’s technology across its facilities while its supply chain, operations and finance teams work with Gallion’s engineering and data science teams on new capabilities. The companies said the work will include AI-enabled features and workflow improvements identified during the pilot.

Gallion’s platform is designed to manage bill-only purchases, which cover medical implants and other supplies that hospitals do not keep in inventory. It connects with electronic health record (EHR) and enterprise resource planning (ERP) systems to validate bill sheets, identify discrepancies and support purchasing and payment workflows in real time.

The deal gives Gallion access to a large academic health system while giving YNHHS a direct role in shaping the product’s development.

From Hospital Workflow To Commercial Platform

Gallion originated at the University of Maryland Medical System (UMMS), where it was developed through iHarbor, the health system’s technology and incubation studio. UMMS spun the company out in 2025, making Gallion the first company to emerge from the innovation center.

The platform addresses a process that can involve clinical documentation, supply chain teams, vendors, billing staff and finance departments. Gallion said its system can compare bill-only documentation with EHR records and contracted ERP pricing while flagging discrepancies before they move further downstream.

That focus puts the partnership within a wider push by health systems to use technology to find and control supply-chain costs. Mount Sinai’s use of AI to identify hidden costs in its supply chain is another example of hospitals applying software to financial and operational data.

Gallion’s own materials describe analytics covering processing times, reconciliation, vendor costs, contract compliance, waste and physician preference item spending. The company also says its platform can automate billing reconciliation and provide real-time alerts when data does not meet specified criteria.

The company did not disclose the financial terms of YNHHS’ investment.

Yale New Haven Adds Development Role

YNHHS operates five hospitals, including Yale New Haven Hospital, and is affiliated with Yale University and Yale Medicine. Its supply chain organization handles the selection, procurement, movement and use of supplies, services and equipment across the system.

The health system has also established programs focused on testing and scaling healthcare technology. Its Center for Health Care Innovation funds projects involving digital health, medical devices and care delivery, while its 2026 Innovation Awards included generative AI and advanced analytics among the areas eligible for support.

YNHHS has separately been testing how AI can move from development into operational and clinical settings. Its 2026 Health AI Symposium included sessions on implementing approved algorithms and scaling applications, while the health system has described its innovation work as focused on practical execution and measurable impact.

The Gallion partnership will focus specifically on bill-only workflows. The companies expect to share progress, including new platform capabilities, over the coming year.

The arrangement also reflects the growing use of technology across healthcare supply chains. Medline’s planned pilot of Symbotic’s AI-powered warehouse automation shows how healthcare suppliers are testing AI and automation in different parts of the supply chain, while Gallion is targeting the financial and documentation workflows that follow clinical use.

Gallion said its platform has been deployed across 12 hospitals within UMMS. Its partnership with YNHHS now gives the company a second major health-system environment in which to develop and test its technology.